Skip to main content

Table 3 Antimicrobial activities for the ethanolic extracts of different wild mushroom strains by using a well diffusion method

From: Molecular identification and antimicrobial activities of some wild Egyptian mushrooms: Bjerkandera adusta as a promising source of bioactive antimicrobial phenolic compounds

Pathogenic microbial strains The diameter of inhibition zone (mm)*
Gentamycin (10 μg/well) Bjerkandera adusta (MN602043) Cyclocybe cylindracea (MN646676) Agrocybe aegerita (MN635615) Chlorophyllum molybdites (MN638772) Lentinus squarrosulus (MN602044)
Gram-positive bacteria Streptococcus pneumoniae 10.0 ± 0.00 17.0 ± 0.20 20.0 ± 0.29 - 12.0 ± 0.33 15.0 ± 0.10
Staphylococcus aureus ATCC25923 8.0 ± 0.00 15.0 ± 0.10 13.0 ± 0.12 - - -
Micrococcus luteus 9.0 ± 0.00 22.0 ± 0.10 14.0 ± 0.22 - - -
Gram-negative bacteria Escherichia coli ATCC25922 2.0 ± 0.00 12.0 ± 0.30 17.0 ± 0.20 2.0 ± 0.00 - -
Pseudomonas aeruginosa ATCC 7853 10.0 ± 0.00 10.0 ± 0.52 17.0 ± 0.00 2.0 ± 0.00 10.0 ± 0.41 20.0 ± 0.22
Proteus mirabilis - - - - - -
Yeast Candida albicans ATCC1031 - 12.0 ± 011 14.0 ± 0.00 - - -
  1. Values for the zone of growth inhibition (measured as the diameter of the clear zone around the well) are means ± SD of three independent replicas. The diameter of the well (5 mm) is included
  2. “-” indicates no inhibition